Brief: FibroGen Announces Leadership Transition
July 25 (Reuters) - FibroGen Inc FGEN.O :
* FIBROGEN ANNOUNCES LEADERSHIP TRANSITION
* FIBROGEN INC - APPOINTS THANE WETTIG AS INTERIM CHIEF
EXECUTIVE
OFFICER
* FIBROGEN INC - WETTIG SUCCEEDS ENRIQUE CONTERNO
* FIBROGEN INC - CONTERNO WILL SERVE AS A SPECIAL ADVISOR TO
CEO
DURING A TRANSITION PERIOD
Source text for Eikon: ID:nGNX7p7NL8
Further company coverage: FGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyntra Bio
See all newsBrief: Kyntra Bio Appoints Andrew E. Singer, Mba To Its Board Of Directors
NASDAQ RESUMED AT 01:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:23 PM
Kyntra Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kyntra Bio swings to profit in Q2 on deconsolidation of subsidiary